貝康醫療－Ｂ(02170.HK)公布2023年止年度業績，收入錄得2.08億人民幣(下同)，按年增加47.6%。虧損由上年度1.23億元，擴至1.92億元，每股虧損7分。不派末期息。
《公司業績》貝康醫療(02170.HK)全年虧損擴至1.92億人民幣
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.